CORCencora, Inc.

$69B

Q4 2023 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$68.9B+12.7% YoY

Gross Profit

$1.9B2.8% margin

Operating Income

$513M0.7% margin

Net Income

$351M0.5% margin

EPS (Diluted)

$1.72

QoQ Revenue Growth

+3.0%

Cash Flow

Operating Cash Flow

$1.8B

Free Cash Flow

$1.7B

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$62.6B

Total Liabilities

$61.9B

Stockholders' Equity

$522M

Cash & Equivalents

$2.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68.9B	$61.2B	+12.7%
Gross Profit	$1.9B	$1.8B	+5.0%
Operating Income	$513M	$552M	-7.0%
Net Income	$351M	$295M	+18.9%

Revenue Segments

Pharmaceutical Distribution

$60.6B88%

International Healthcare Solutions

$7.0B10%

Animal Health

$1.3B2%

Geographic Segments

U.S. Healthcare Solutions

$61.9B90%

International Healthcare Solutions

$7.0B10%

COR Q4 2023 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena